Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kurzrock

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Oncology (Williston Park, N.Y.)|October 18, 2000
rhIL-11 for the prevention of dose-limiting chemotherapy-induced thrombocytopeniaR Kurzrock
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 5, 2002
Cytokine deregulation in cancerR Kurzrock
Annals of the New York Academy of Sciences|October 12, 2001
Therapy of T cell lymphomas with pentostatinR Kurzrock
Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) in T-cell lymphomasR Kurzrock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Cytokine deregulation in hematological malignancies: clinical and biological implicationsR Kurzrock
Cancer|October 13, 2001
The role of cytokines in cancer-related fatigueR Kurzrock
Leukemia & Lymphoma|July 1, 1997
Interleukin-10 in non-Hodgkin's lymphomaJ Cortes, R Kurzrock
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2024
The best management for most patients with incurable cancer is on a clinical trialV Subbiah, R Kurzrock
British Journal of Haematology|October 1, 1991
The molecular pathology of chronic myelogenous leukaemiaR Kurzrock, M Talpaz
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2026
Next-Generation Sequencing Consensus Guidelines for Sarcoma: Progress, Gaps, and the Path ForwardV Subbiah, R Kurzrock
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Oncology (Williston Park, N.Y.)|October 18, 2000
rhIL-11 for the prevention of dose-limiting chemotherapy-induced thrombocytopeniaR Kurzrock
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 5, 2002
Cytokine deregulation in cancerR Kurzrock
Annals of the New York Academy of Sciences|October 12, 2001
Therapy of T cell lymphomas with pentostatinR Kurzrock
Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) in T-cell lymphomasR Kurzrock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Cytokine deregulation in hematological malignancies: clinical and biological implicationsR Kurzrock
Cancer|October 13, 2001
The role of cytokines in cancer-related fatigueR Kurzrock
Leukemia & Lymphoma|July 1, 1997
Interleukin-10 in non-Hodgkin's lymphomaJ Cortes, R Kurzrock
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2024
The best management for most patients with incurable cancer is on a clinical trialV Subbiah, R Kurzrock
British Journal of Haematology|October 1, 1991
The molecular pathology of chronic myelogenous leukaemiaR Kurzrock, M Talpaz
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2026
Next-Generation Sequencing Consensus Guidelines for Sarcoma: Progress, Gaps, and the Path ForwardV Subbiah, R Kurzrock
Pageof 25